Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Noriko Kanamaru"'
Autor:
Masaji Okada, Yoko Kita, Noriko Kanamaru, Satomi Hashimoto, Yasushi Uchiyama, Masahiko Mihara, Yoshikazu Inoue, Yoshiyuki Ohsugi, Tadamitsu Kishimoto, Mitsunori Sakatani
Publikováno v:
Clinical and Developmental Immunology, Vol 2011 (2011)
Objective. Our aim was to investigate the effects of IL-6 blockade on the progression of Mycobacterium tuberculosis (TB) and compare them with those of TNF-α blockade in mice. Methods. Mice were intravenously infected with TB and injected with antib
Externí odkaz:
https://doaj.org/article/630960e866234d10a47fe6308fe37e18
Autor:
Masaji Okada, Yoko Kita, Toshihiro Nakajima, Noriko Kanamaru, Satomi Hashimoto, Tetsuji Nagasawa, Yasufumi Kaneda, Shigeto Yoshida, Yasuko Nishida, Hitoshi Nakatani, Kyoko Takao, Chie Kishigami, Shiho Nishimatsu, Yuki Sekine, Yoshikazu Inoue, David N. McMurray, Mitsunori Sakatani
Publikováno v:
Clinical and Developmental Immunology, Vol 2011 (2011)
Objective. Mycobacterium tuberculosis infection is a major global threat to human health. The only tuberculosis (TB) vaccine currently available is bacillus Calmette-Guérin (BCG), although it has no efficacy in adults. Therefore, the development of
Externí odkaz:
https://doaj.org/article/d8a9829150704364920f68a1c9436ded
Autor:
Yasushi Takamori, E.C. Dela Cruz, Shiho Nishimatsu, David N. McMurray, Satomi Hashimoto, Yoko Kita, Noriko Kanamaru, Paul Saunderson, Masaji Okada, Marjorie L. Cang, Y. Kaneda, Yasuko Nishida, Esterlina V. Tan, Toshihiro Nakajima, Hitoshi Nakatani
Publikováno v:
Human Vaccines & Immunotherapeutics
Purpose: Multi-drug resistant tuberculosis (MDR-TB) and extremely drug resistant (XDR) TB are big problems in the world. We have developed novel TB therapeutic vaccines, HVJ-Envelope/HSP65 + IL-12 DNA vaccine (HSP65-vaccine), granulysin vaccine and k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c712737b15f464863c191042d03efc5a
Autor:
Yasufumi Kaneda, Esterlina V. Tan, Yoko Kita, Toshihiro Nakajima, Noriko Kanamaru, Paul Saunderson, David N. McMurray, Masaji Okada
Publikováno v:
Procedia in Vaccinology
We have developed a novel tuberculosis (TB) vaccine; a combination of the DNA vaccines expressing mycobacterial heat shock protein 65 (HSP65) and interleukin 12 (IL-12) delivered by the hemagglutinating virus of Japan (HVJ)-envelope and –liposome (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b91b948faa3294d82dbc70d74f8ad7fc
https://doi.org/10.1016/j.provac.2011.07.007
https://doi.org/10.1016/j.provac.2011.07.007
Autor:
Shiho Nishimatsu, Yuki Sekine, Satomi Hashimoto, Hitoshi Nakatani, Yoko Kita, Mitsunori Sakatani, Yoshikazu Inoue, Yasuko Nishida, Masaji Okada, Tetsuji Nagasawa, Chie Kishigami, Esterlina V. Tan, Toshihiro Nakajima, David N. McMurray, Makoto Matsumoto, Shigeto Yoshida, Kyoko Takao, Noriko Kanamaru, E.C. Dela Cruz, Saunderson Paul, Y. Kaneda
Publikováno v:
Procedia in Vaccinology
We have developed a novel tuberculosis (TB) vaccine; a combination of the DNA vaccines expressing mycobacterial heat shock protein 65 (HSP65) and interleukin 12 (IL-12) delivered by the hemagglutinating virus of Japan (HVJ)-envelope and –liposome (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a93dc7b17e08e4a591a613072973e0df
Autor:
Masaji Okada, Jasmin Burgos, Toshihiro Nakajima, Yasuko Nishida, Kyoko Takao, Hitoshi Nakatani, Noriko Kanamaru, Paul Saunderson, Makoto Matsumoto, Yoshikazu Inoue, Rodolfo M. Abalos, David N. McMurray, Mitsunori Sakatani, Yoko Kita, Esterlina V. Tan, Tetsuji Nagasawa, E.C. Dela Cruz, Shigeto Yoshida, Satomi Hashimoto, Chie Kishigami, Yasufumi Kaneda
Publikováno v:
Vaccine. 27:3267-3270
We have developed a novel tuberculosis (TB) vaccine; a combination of the DNA vaccines expressing mycobacterial heat shock protein 65 (HSP65) and interleukin 12 (IL-12) delivered by the hemagglutinating virus of Japan (HVJ)-envelope and -liposome (HS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a21fca9e4d7a9523432f04fa114a1ff
https://doi.org/10.1016/j.vaccine.2009.01.064
https://doi.org/10.1016/j.vaccine.2009.01.064
Autor:
Yukio Koide, Sachiko Kuwayama, Hideki Nakano, Toshi Nagata, Taiki Aoshi, Kingo Chida, Masato Uchijima, Noriko Kanamaru, Hirotoshi Nakamura, Masaji Okada, Takafumi Suda, Takao Tanaka
Publikováno v:
Vaccine. 24:2110-2119
In the present study, we evaluated antigen 85A (Ag85A) gene-transduced dendritic cells (DCs) vaccine against Mycobacterium tuberculosis. Murine bone marrow-derived DCs were retrovirally transduced with mycobacterial Ag85A gene and injected to BALB/c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f34cc166c72789c122d5dfaee64c2f82
https://doi.org/10.1016/j.vaccine.2005.11.026
https://doi.org/10.1016/j.vaccine.2005.11.026
Autor:
Yoko Kita, Hiroko Takai, Yoshinobu Okuno, Daphne E. deMello, Yumiko Muraki, Takao Tanaka, Shigeto Yoshida, Masaji Okada, Yuji Takemoto, Yayoi Sakaguchi, Yoshiyuki Yoshinaka, Kyoko Yamada, Chika Okada, Masato Tashiro, Tetsuo Kase, Naoki Yamamoto, Shigeru Morikawa, Joseph S. M. Peiris, Yukari Fukunaga, Tatsuji Nomura, Pei-Jer Chen, Sachiko Kuwayama, Noriko Kanamaru, Isao Ishida, Satomi Hashimoto, Makoto Matsumoto, Izumi Furukawa, Mitsunori Sakatani
Publikováno v:
Vaccine
We have investigated to develop novel vaccines against SARS CoV using cDNA constructs encoding the structural antigen; spike protein (S), membrane protein (M), envelope protein (E), or nucleocapsid (N) protein, derived from SARS CoV. Mice vaccinated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bdb9a0108e871a03177a6589779ca48
https://doi.org/10.1016/j.vaccine.2005.01.036
https://doi.org/10.1016/j.vaccine.2005.01.036
Autor:
Hitoshi Nakatani, Yoko Kita, Yasushi Takamori, Marjorie L. Cang, Yasuko Nishida, E.C. Dela Cruz, Toshihiro Nakajima, Shiho Nishimatsu, Esterlina V. Tan, Y. Kaneda, David N. McMurray, Noriko Kanamaru, Paul Saunderson, Masaji Okada, Satomi Hashimoto
Results: HSP65 + IL-12 DNA vaccine showed higher protective efficacy compared with BCG in both mouse and monkey models of TB. It induced the TB-specific CTL in the mouse model of TB, while little level of activity was observed after the injection of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddda2629cdabdfcfb7d890a0b3478307
https://europepmc.org/articles/PMC3891707/
https://europepmc.org/articles/PMC3891707/
Autor:
Satomi Hashimoto, Yoshikazu Inoue, Tetsuji Nagasawa, Mitsunori Sakatani, Shigeto Yoshida, Jasmin Burgos, Makoto Matsumoto, Esterlina V. Tan, Masaji Okada, Hitoshi Nakatani, E C De la Cruz, Kyoko Takao, Noriko Kanamaru, Paul Saunderson, Rodolfo M. Abalos, Toshihiro Nakajima, Yasuko Nishida, Chie Kishigami, David N. McMurray, Shiho Nishimatsu, Yuki Sekine, Yasufumi Kaneda, Yoko Kita
Publikováno v:
Human vaccines.
Multi-drug resistant (MDR) Mycobacterium Tuberculosis (M.TB) is a big problem in the world. We have developed novel TB therapeutic vaccines.DNA vaccine expressing mycobacterial heat shock protein 65 and IL-12 was delivered by the hemagglutinating vir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::893c90257b8f9bb92f59f0b92f3f1680
https://pubmed.ncbi.nlm.nih.gov/21546794
https://pubmed.ncbi.nlm.nih.gov/21546794